(Alliance News) - Laboratorio Farmaceutico Erfo Spa reported Tuesday that it closed the half-year with a profit of EUR470,000, in line with the 2022 profit of EUR480,000.

As of June 30, revenues amounted to EUR3.4 million, up 21 percent from EUR2.8 million in 2022.

The number of active Diètnatural franchise centers as of June 30 was 108. There were three net franchise openings in the six-month period.

As of June 30, the number of direct centers was 11, in addition to one direct center in Spain, which up to that date had been solely for the purpose of exploring new development opportunities in the territory. The number of centers in France under the Bodysano brand as of June 30 was 26, plus one direct center in Belgium.

Ebitda for the first half was EUR1.0 million, the same as adjusted and in line with 2022.

Adjusted Net Financial Position is cash positive and EUR1.5 million, an improvement from December 31, 2022 when it was EUR1.0 million.

Laboratorio Farmaceutico Erfo on Tuesday closed 0.8 percent in the red at EUR1.18 per share.

By Claudia Cavaliere, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Copyright 2023 Alliance News IS Italian Service Ltd. All rights reserved.